The Lipid Raft Hypothesis: The Relation among Omega-3 Fatty Acids, Depression and Cardiovascular Diseases

脂筏(lipid raft)理論的觀點：Omega-3多元不飽合脂肪酸與憂鬱症及心血管疾病之關係

10.29478/TJP.201009.0003

張倍禎(Jane Pei-Chen Chang)；蘇冠賓(Kuan-Pin Su)

魚油 ； 心血管疾病 ； 憂鬱症 ； 脂筏 ； depression ； cardiovascular diseases ； n-3 PUFAs ； lipid rafts

台灣精神醫學

24卷3期（2010 / 09 / 01）

168 - 180

英文

前言：世界衛生組織指出，憂鬱症及心血管疾病即將於西元2020年成為兩大最主要提早死亡及失能的原因。憂鬱症經常合併心血管疾病，而身體症狀更是憂鬱症患者就醫之主因，再加上傳統單胺酸作用的抗憂鬱劑療效並不理想，種種現象皆顯示出目前最盛行的單胺酸假說在探討憂鬱症的病因上之不足。方法：我們回顧了所有omega-3多元不飽合脂肪酸（縮寫為n-3出PUFAs，或俗稱深海魚油）與脂筏(lipid rafts)相關的近期發表文獻並進一步探討他們在心血管疾病與憂鬱症所扮演的角色。結果：在文獻回顧中，從流行病學、神經生理學及療效研究中發現，n-3 PUFAs分別與心血管疾病和憂鬱症的病因都有密切的關連，omega-3 PUFAs是人類生存的必需脂肪酸，具有神經功能維護及抑制過度發炎反應的生理功能，也可以影響「下視丘－腦垂體－腎上腺軸」所引發的自律神經系統的功能。因此探討憂鬱症的病因，除了最盛行的血清素（單胺酸）假說外，脂肪酸假說是目前一個前瞻且重要的方向。近期的研究發現脂筏，是一種細胞膜上富含cholesterol及sphingolipids之特殊脂類、且對界面活性劑有抗性的特殊微小構造。脂筏可藉由提供功能性的膜環境來調控細胞中重要的生理反應，例如：訊息傳遞、細胞膜上分子運輸、可塑性、移動、防衛及免疫系統。由於基礎研究與動物研究發現，omega-3 PUFAs具有調控脂筏的功能，亦可影響細胞間訊息傳遞及分子運輸，更能進一步調節內分泌、自律神經及免疫系統等功能。結論：因此，本文將探討omega-3多元不飽合脂肪酸的調控脂筏功能及其在於心血管疾病與憂鬱症中所扮演的角色。希望能藉由更多脂筏與omega-3多元不飽合脂肪酸的研究，可以提供給「傷心」的病人更好的治療。

Background: Depression and cardiovascular diseases (CVDs) exist frequently as comorbid conditions, suggesting their common etiologies. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) play important roles in inflammation and brain functions, and they appear to be a possible interface between depression and CVDs. Methods: We reviewed all recently published papers on n-3 PUFAs and lipid rafts to look for their implications in causing CVDs and depression. Results: In the literature, we found that lipid raft formations and disruptions are critically important in regulating of neurotransmission signaling and receptor functions, which in turn might be involved in causing depression and CVDs. In addition to neurotransmission, n-3 PUFAs have shown to possibly regulate immunity and neuroendocrine function via lipid raft modulations. Conclusion: This review has provided evidences for the role of n-3 PUFAs in causing depression and CVD. We also propose a new hypothesis about cellular mechanisms mediated by lipid rafts.

1. Albert, C.M.,Campos, H.,Stampfer, M.J.(2002).Blood levels of long-chain n-3 fatty acids and the risk of sudden death.N Engl J Med,346,1113-8.
2. Berton, O.,Nestler, E.J.(2006).New approaches to antidepressant drug discovery: beyond monoamines.Nat Rev Neurosci,7,137-51.
3. Bruses, J.L.,Chauvet, N.,Rutishauser, U.(2001).Membrane lipid rafts are necessary for the maintenance of the (alpha) 7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons.J Neurosci,21,504-12.
4. Bucci, M.,Gratton, J.P.,Rudic, R.D.(2000).In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.Nat Med,6,1362-7.
5. Butchbach, M.E.,Guo, H.,Lin, C.L.(2003).Methyl-beta-cyclo-dextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression.J Neurochem,84,891-4.
6. Chang, J.,Chen, Y.,Su, K.(2009).Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: the missing link?.Cardiovasc Psychiatry Neurol,2009,1-6.
7. Chiu, C.C.,Huang, S.Y.,Chen, C.C.(2005).Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.J Clin Psychiatry,66,1613-4.
8. Chun, M.,Liyanage, U.K.,Lisanti, M.P.(1994).Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin.Proc Natl Acad Sci USA,91,11728-32.
9. Clamp, A.G.,Ladha, S.,Clark, D.C.(1997).The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membrane.Lipids,32,179-84.
10. Colaizzo, D.,Fofi, L.,Tiscia, G.(2006).The COX-2 G/C-765 polymorphism may modulate the occurrence of cerebrovascular ischemia.Blood Coagul Fibrinolysis,17,93-6.
11. Das, M.,Gherghiceanu, M.,Lekli, I.(2008).Essential role of lipid raft in ischemic preconditioning.Cell Physiol Biochem,21,325-34.
12. Das, U.N.(2006).Essential fatty acids: biochemistry, physiology and pathology.Biotechnol J,1,420-39.
13. Donati, R.J.,Dwivedi, Y.,Roberts, R.C.(2008).Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase.J Neurosci,28,3042-50.
14. Franco, V.,Chen, Y.F.,Oparil, S.(2004).Atrial natriuretic peptide dose-dependently inhibits pressure overloadinduced cardiac remodeling.Hypertension,44,746-50.
15. Giorgione, J.,Epand, R.M.,Buda, C.(1995).Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C.Proc Natl Acad Sci USA,92,9767-70.
16. Hamazaki, T.,Sawazaki, S.,Itomura, M.(1996).The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled double-blind study.J Clin Invest,97,1129-33.
17. Hibbeln, J.R.,Bissette, G.,Umhau, J.C.(2004).Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence.Biol Psychiatry,56,895-7.
18. Hibbeln, J.R.,Nieminen, L.R.,Blasbalg, T.L.(2006).Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity.Am J Clin Nutr,82,1483S-93S.
19. Holowka, D.,Baird, B.(2001).Fc(epsilon)RI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells.Semin Immunol,13,99-105.
20. Janes, P.W.,Ley, S.C.,Magee, A.I.(2000).The role of lipid rafts in T cell antigen receptor (TCR) signalling.Semin Immunol,12,23-34.
21. Kitzlerova, E.,Anders, M.(2007).The role of some new factors in the pathophysiology of depression and cardiovascular disease: overview of recent research.Neuro Endocrinol Lett,28,832-40.
22. Krishnan, V.,Nestler, E.J.(2008).The molecular neurobiology of depression.Nature,455,894-902.
23. Lesperance, F.,Frasure-Smith, N.(2003).Depression and coronary artery disease: time to move from observation to trials.CMAJ,168,570-1.
24. Lin, P.Y.,Huang, S.Y.,Su, K.P..A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression.Biol Psychiatry
25. Lin, P.Y.,Su, K.P.(2007).A meta-analytic review of doubleblind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.J Clin Psychiatry,68,1056-61.
26. Maguy, A.,Hebert, T.E.,Nattel, S.(2006).Involvement of lipid rafts and caveolae in cardiac ion channel function.Cardiovasc Res,69,798-807.
27. Mori, T.A.,Burke, V.,Puddey, I.B.(2000).Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.Am J Clin Nutr,71,1085-94.
28. Murck, H.,Song, C.,Horrobin, D.F.(2004).Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression.Int J Neuropsychopharmacol,7,341-9.
29. Murray, C.J.,Lopez, A.D.(1996).Evidence-based health policy-lessons from the Global Burden of Disease Study.Science,274,740-3.
30. Musselman, D.L.,Evans, D.L.,Nemeroff, C.B.(1998).The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.Arch Gen Psychiatry,55,580-92.
31. Nicolau, D.V.Jr.,Burrage, K.,Parton, R.G.(2006).Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane.Mol Cell Biol,26,313-23.
32. Nieminen, L.R.,Makino, K.K.,Mehta, N.(2006).Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls.Prostaglandins Leukot Essent Fatty Acids,75,309-14.
33. Noponen, M.,Sanfilipo, M.,Samanich, K.(1993).Elevated PLA2 activity in schizophrenics and other psychiatric patients.Biol Psychiatry,34,641-9.
34. Oh, P.,Schnitzer, J.E.(2001).Segregation of heterotrimeric G proteins in cell surface microdomains. G (q) binds caveolin to concentrate in caveolae, whereas G (i) and G (s) target lipid rafts by default.Mol Biol Cell,12,685-98.
35. Orbe, J.,Beloqui, O.,Rodriguez, J.A.(2006).Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.Clin Chim Acta,368,138-43.
36. Ostrom, R.S.,Violin, J.D.,Coleman, S.(2000).Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.Mol Pharmacol,57,1075-9.
37. Pae, C.U.,Yu, H.S.,Kim, J.J.(2004).BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population.Neuropsychobiology,49,185-8.
38. Papafili, A.,Hill, M.R.,Brull, D.J.(2002).Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflamatory response.Arterioscler Thromb Vasc Biol,22,1631-6.
39. Park, D.S.,Woodman, S.E.,Schubert, W.(2002).Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.Am J Pathol,160,2207-17.
40. Peet, M.,Murphy, B.,Shay, J.(1998).Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients.Biol Psychiatry,43,315-9.
41. Penninx, B.W.,Beekman, A.T.,Honig, A.(2001).Depression and cardiac mortality: results from a community-based longitudinal study.Arch Gen Psychiatry,58,221-7.
42. Rosmond, R.,Bjorntorp, P.(2000).The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke.J Intern Med,247,188-97.
43. Russo, G.L.(2009).Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.Biochem Pharmacol,77,937-46.
44. Scanlon, S.M.,Williams, D.C.,Schloss, P.(2001).Membrane cholesterol modulates serotonin transporter activity.Biochemistry,40,10507-13.
45. Scheiffele, P.,Rietveld, A.,Wilk, T.(1999).Influenza viruses select ordered lipid domains during budding from the plasma membrane.J Biol Chem,274,2038-44.
46. Schwellenbach, L.J.,Olson, K.L.,McConnell, K.J.(2006).The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.J Am Coll Nutr,25,480-5.
47. Simons, K.,Toomre, D.(2001).Lipid rafts and signal transduction.Nat Rev Mol Cell Biol,1,31-9.
48. Steinburg, S.(2004).Beta 2-adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts.J Clin Cellu Molecul Cardiol,37,407-15.
49. Stillwell, W.,Shaikh, S.R.,Zerouga, M.(2005).Docosahexaenoic acid affects cell signaling by altering lipid rafts.Reprod Nutr Dev,45,559-79.
50. Strokin, M.,Sergeeva, M.,Reiser, G.(2003).Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+.Br J Pharmacol,139,1014-22.
51. Su, K.P.(2009).Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a "mind-body interface"?.Neurosignals,17,144-52.
52. Su, K.P.(2008).Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.Asia Pac J Clin Nutr,17(Suppl 1),151-7.
53. Su, K.P.,Huang, S.Y.,Chiu, C.C.(2003).Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.Eur Neuropsychopharmacol,13,267-71.
54. Su, K.P.,Huang, S.Y.,Peng, C.Y.(2010).Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.Biol Psychiatry,67,550-7.
55. Takeuchi, T.,Iwanaga, M.,Harada, E.(2003).Possible regulatory mechanism of DHA-induced anti-stress reaction in rats.Brain Res,964,136-43.
56. Trushina, E.,Du, C.J.,Parisi, J.(2006).Neurological abnormalities in caveolin-1 knock out mice.Behav Brain Res,172,24-32.
57. Whelton, S.P.,He, J.,Whelton, P.K.(2004).Meta-analysis of observational studies on fi sh intake and coronary heart disease.Am J Cardiol,93,1119-23.
58. Wolbink, G.J.,Schalkwijk, C.,Baars, J.W.(1995).Therapy with interleukin-2 induces the systemic release of phospholipase-A2.Cancer Immunol Immunother,41,287-92.
59. Wu, T.,Levine, S.J.,Lawrence, M.G.(1994).Interferongamma induces the synthesis and activation of cytosolic phospholipase A2.J Clin Invest,93,571-7.
60. Yokoyama, M.,Origasa, H.,Matsuzaki, M.(2007).Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis.Lancet,369,1090-8.